Body-recomposition stack

Ipamorelin + HGH Fragment 176-191 stack

A research-context overview of stacking Ipamorelin with HGH Fragment 176-191: the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.

Why this stack?

Stacking a Metabolic agent (HGH Fragment 176-191) with a Performance / GH-axis compound (Ipamorelin) is the canonical body-recomposition pattern: the GLP-1 / metabolic compound drives caloric deficit and visceral-fat reduction, while the GH-axis compound preserves lean mass and accelerates training-tissue repair under that deficit. Researchers running this pair typically titrate the metabolic agent up first, then layer the GH-axis compound once dose tolerance is established.

Performance

Ipamorelin

Gentle GH releaser that amps muscle growth and fat loss without the harsh sides.

Key benefits

  • Increases lean muscle mass
  • Accelerates fat loss
  • Improves sleep quality
  • Enhances recovery

Side effects to watch

  • Flushing
  • Headache
  • Lightheadedness
Reference dose
200-300 mcg · Daily (Night)
Metabolic

HGH Fragment 176-191

Fat Loss Peptide without the growth effects.

Key benefits

  • Fat loss
  • Inhibits fatty acid formation
  • No blood sugar impact

Side effects to watch

  • Injection site pain
  • Itching
Reference dose
250-500 mcg · 1-2 times daily

Half-life considerations

Reference half-life data for one or both of these compounds is not in our table — see the individual peptide profiles for cited PK ranges.

Profile
Ipamorelin
Profile
HGH Fragment 176-191
Compare
Ipamorelin vs HGH Fragment 176-191

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.